Related content

Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer

By de Lange S.M.   van Groeningen C.J.   Meijer O.W.M.   Cuesta M.A.   Langendijk J.A.   van Riel J.M.G.H.   Pinedo H.M.   Peters G.J.   Meijer S.   Slotman B.J.   Giaccone G.  

European Journal of Cancer, Vol. 38, Iss. 9, 2002-06 ,pp. : 1212-1217

Elsevier

Access to resources Recommend Favorite

Phase II Study of Gemcitabine, UFT and Leucovorin in Patients with Advanced Pancreatic Cancer

By Kim Tae Won   Kang Hae Jin   Ahn Jin Hee   Lee Keehyun   Chang Heung Moon   Kang Yoon Koo   Lee Jung Shin  

Acta Oncologica, Vol. 41, Iss. 7-8, 2002-11 ,pp. : 689-694

Informa Healthcare

Access to resources Recommend Favorite

Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer

By Song Hunho   Han Boram   Park Choong   Kim Jong   Jeon Jang   Kim In-Gyu   Kim Hyo   Jung Joo   Kim Jung   Kwon Jung   Jang Geundoo   Kim Ho   Kim Hyeong   Choi Dae   Zang Dae  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 4, 2013-10 ,pp. : 845-852

Springer Publishing Company

Access to resources Recommend Favorite

Concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer

By  

Medical Oncology, Vol. 24, Iss. 2, 2007-06 ,pp. : 239-243

Humana Press, Inc

Access to resources Recommend Favorite

Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine

By Saad Everardo   Machado Marcel   Wajsbrot Dalia   Abramoff Roberto   Hoff Paulo   Tabacof Jacques   Katz Artur   Simon Sergio   Gansl René  

International Journal of Gastrointestinal Cancer, Vol. 32, Iss. 1, 2002-08 ,pp. : 35-41

Humana Press, Inc

Access to resources Recommend Favorite